Search results for "inflammation"

showing 10 items of 2662 documents

Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory …

2011

See related article, Oostlander AE et al, on page 116 in Gastroenterology. BACKGROUND & AIMS: Few data are available on effects of biologic therapies in patients more than 65 years old with inflammatory bowel disease (IBD). We evaluated the risk and benefits of therapy with tumor necrosis factor (TNF) inhibitors in these patients. METHODS: We collected data from patients with IBD treated with infliximab (n 2475) and adalimumab (n 604) from 2000 to 2009 at 16 tertiary centers. Ninety-five patients (3%) were more than 65 years old (52 men; 37 with ulcerative colitis and 58 with Crohn’s disease; 78 treated with infliximab and 17 with adalimumab). The control group comprised 190 patients 65 yea…

MaleAgingSettore MED/09 - Medicina InternaBiologicantagonists /&/ inhibitors/immunology Young AdultInflammatory bowel diseaseHumanized AntibodieElderlyNeoplasmsMonoclonalYoung adultAged 80 and overSettore MED/12 - GastroenterologiaCrohn's diseaseGastroenterologyAge FactorsAntibodies MonoclonalMiddle AgedUlcerative colitisepidemiology Opportunistic InfectionFemaleDrug ComplicationSafetymedicine.drugAdultmedicine.medical_specialtyAdolescentIBDOpportunistic InfectionsAntibodies Monoclonal HumanizedYoung AdultInternal medicinemedicineAdalimumab80 and over AntibodieHumansImmunologic FactorsRisk factoradverse effects/therapeutic use Inflammatory Bowel DiseaseAgedHepatologymortality/therapy Male Middle Aged Neoplasmepidemiology Tumor Necrosis Factor-alphabusiness.industryTumor Necrosis Factor-alphaAdalimumabmedicine.diseaseInflammatory Bowel DiseasesCrohn's Disease Activity IndexInfliximabInfliximabSurgeryInflammation Side Effects Drug ComplicationsSide Effectinflammationadverse effects/therapeutic use Female Humans Immunologic FactorAdolescent Adult Age Factors Aged Agedbusiness
researchProduct

C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) as inflammation markers in elderly patients with stable chronic obstructive pulmona…

2010

Erythrocyte sedimentation rate (ESR) might represent a less expensive alternative to C-reactive protein (CRP) as a marker of systemic inflammation in stable chronic obstructive pulmonary disease (COPD). We tried to verify this hypothesis in 223 consecutive outpatients aged 65 years or more with stable COPD enrolled in a multicenter observational study. Patients were grouped according to normal/increased ESR/CRP values and groups were compared with regard to clinical and laboratory characteristics. Correlations between CRP, ESR and selected variables of interest were assessed by Spearman's ζ-test and multivariate linear regression analysis. CRP was weakly and inversely correlated with the fo…

MaleAgingmedicine.medical_specialtyHealth (social science)AnemiaBlood SedimentationSettore MED/10 - Malattie Dell'Apparato RespiratorioSystemic inflammationSeverity of Illness IndexGastroenterologyPulmonary Disease Chronic ObstructiveInternal medicineBayesian multivariate linear regressionSeverity of illnessmedicineHumansCOPDHypoalbuminemiaAgedInflammationCOPDmedicine.diagnostic_testbiologybusiness.industryC-reactive proteinPrognosismedicine.diseaseSurgeryC-Reactive ProteinErythrocyte sedimentation ratebiology.proteinFemaleGeriatrics and Gerontologymedicine.symptombusinessGerontologyBiomarkersFollow-Up Studies
researchProduct

Inflammatory activation and endothelial dysfunction markers in patients with permanent atrial fibrillation: A cross-sectional study

2020

In recent years a growing body of evidence supported the role of inflammation in the initiation, maintenance and outcome of atrial fibrillation (AF). Nevertheless, despite a large amount of information, whether AF or the underlying structural heart disease (SHD) is the cause of the inflammatory process is still under debate. We, therefore, sought to determine if the inflammatory process reflect an underlying disease or the arrhythmia 'per se'. We evaluated plasma levels of soluble Interleukin 2 Receptor Alpha (sIL-2Rα), TNF-α and IL-18 in 100 consecutive patients with permanent AF, (43 with a SHD and 57 without a SHD) compared to 121 age and sex-matched controls which had normal sinus rhyth…

MaleAgingmedicine.medical_specialtyHeart diseaseAlpha (ethology)InflammationDiseaseSystemic inflammationendothelial dysfunctionInternal medicineAtrial FibrillationmedicineHumansEndothelial dysfunctionReactive hyperemiaAgedAged 80 and overInflammationTumor Necrosis Factor-alphabusiness.industryInterleukin-18Interleukin-2 Receptor alpha SubunitAtrial fibrillationAtrial fibrillation Cytokines Endothelial dysfunction Inflammation Structural heart diseaseCell BiologyMiddle Agedmedicine.diseasestructural heart diseasecytokinesCross-Sectional StudiesLogistic ModelsROC CurveCase-Control StudiesCardiologyFemaleEndothelium Vascularmedicine.symptombusinessBiomarkersResearch Paper
researchProduct

Analysis of early biochemical markers and regulation by tin protoporphyrin IX in a model of spontaneous osteoarthritis

2011

Abstract Age-related changes in joint tissues lead to osteoarthritis (OA). Detection of early changes in OA patients may help to initiate treatments before the establishment of irreversible joint destruction. STR/ort mice develop with age a severe degenerative joint disease that resembles human OA thus allowing the investigation of biochemical markers as well as new treatments in an accelerated time frame. We have analyzed the changes in serum levels of different mediators during the early phases of idiopathic OA in STR/ort mice. Serum levels of matrix metalloproteinase-3 (MMP-3) but not those of tumor necrosis factor-α, interleukin(IL)-1β, IL-17 or prostaglandin E 2 correlated with histopa…

MaleAgingmedicine.medical_specialtyPathologyMetalloporphyrinsmedicine.medical_treatmentDrug Evaluation PreclinicalProtoporphyrinsMice Inbred StrainsOsteoarthritisMatrix metalloproteinaseBiochemistryMiceEndocrinologyInternal medicineOsteoarthritisGeneticsmedicineAnimalsEnzyme InhibitorsMolecular BiologyBiochemical markersbusiness.industryInterleukinCell BiologyClinical Enzyme TestsTin protoporphyrin IXmedicine.diseaseArthritis ExperimentalEarly DiagnosisEndocrinologyHeme Oxygenase (Decyclizing)Disease ProgressionBiomarker (medicine)Matrix Metalloproteinase 3Tumor necrosis factor alphaInflammation MediatorsbusinessBiomarkersProstaglandin EExperimental Gerontology
researchProduct

The cortisol burden in elderly subjects with metabolic syndrome and its association with low-grade inflammation

2019

Background: Elderly people are exposed to an increased load of stressful events and neuro-hormonal stimulation is a key finding in metabolic syndrome and its related disorders. Aims: To determine the role of cortisol in elderly subjects, with or without metabolic syndrome (MetS), by means of a national multicentre observational study, AGICO (AGIng and Cortisol). Methods: From 2012 to 2017, the AGICO study enrolled n.339 subjects (aged > 65), after obtaining their informed consent. The investigators assessed a cardio-metabolic panel (including electrocardiogram, carotid ultrasonography and echocardiography), the presence of MetS (on Adult Treatment Panel III criteria), a neurological exam…

MaleAgingmedicine.medical_specialtySettore MED/09 - Medicina InternaHydrocortisoneUrinary systemNeurological examinationUrineGastroenterologyCortisolaging; cortisol; Inflammation; metabolic syndrome; aged; aged; 80 and over; echocardiography; female; humans; hydrocortisone; inflammation; male; metabolic syndromeExcretionAging; Cortisol; Inflammation; Metabolic syndrome; Aged; Aged 80 and over; Echocardiography; Female; Humans; Hydrocortisone; Inflammation; Male; Metabolic Syndrome03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicine80 and overmedicineHumans030212 general & internal medicineAgedAged 80 and overInflammationCreatininemedicine.diagnostic_testbusiness.industryCarotid ultrasonographymedicine.diseaseMetabolic syndromechemistryEchocardiographyFemaleGeriatrics and GerontologyMetabolic syndromebusiness030217 neurology & neurosurgeryHormone
researchProduct

Measurement of inflammatory mediators of mast cells and eosinophils in native nasal lavage fluid in nasal polyposis.

2001

<i>Background:</i> Nasal polyposis (NP) often coexists with asthma, rhinitis and sinusitis. Polyp histology typically shows chronic, eosinophilic inflammation. The inflammatory cell infiltrate generally includes eosinophils, lymphocytes, plasma cells and mast cells. <i>Objective:</i> To gain insight into the natural history of NP, we analysed mediator levels and leukocyte values in nasal fluids and eosinophil cationic protein (ECP), total IgE levels and eosinophils in the blood in several groups of both allergic and non-allergic patients with nasal polyps and in patients with allergic rhinitis (AR). <i>Methods:</i> Thirty-two patients with nasal polyps en…

MaleAllergyPathologyImmunoglobulin ESeverity of Illness IndexLeukocyte CountImmunology and AllergyMedicineMast CellsSinusitisEosinophil cationic proteinMitesbiologySerine EndopeptidasesGeneral MedicineBlood Proteinsrespiratory systemEosinophil Granule ProteinsMiddle AgedMast cellBody Fluidsmedicine.anatomical_structurePollenFemaleNasal Lavage FluidInflammation MediatorsNasal CavityHistamineAdultmedicine.medical_specialtyRhinitis Allergic PerennialAdolescentImmunologyTryptaseNasal PolypsRibonucleasesEosinophiliaotorhinolaryngologic diseasesAnimalsHumansTherapeutic IrrigationSkin Testsbusiness.industryRhinitis Allergic SeasonalEosinophilImmunoglobulin Emedicine.diseaseEosinophilsImmunologybiology.proteinTryptasesbusiness
researchProduct

Noninvasive methods for the detection of upper and lower airway inflammation in atopic children

2006

Background Exhaled nitric oxide (FE NO ) and exhaled breath condensate (EBC) are noninvasive methods to assess inflammation. Objective To investigate the role of the FE NO and of the EBC pH and IL-5 levels in atopic children. Methods We evaluated oral and nasal FE NO and the pH and IL-5 of oral and nasal EBC in children with atopic dermatitis (AD; n=18), allergic rhinitis (AR; n=18), intermittent asthma (n = 21), moderate persistent asthma (n = 18), and healthy controls (HCs; n=16). Results Oral FE NO was significantly increased in asthma, whereas the nasal values were increased in AR and asthma in comparison with HCs. The pH of oral EBC was lower in AD and asthma than in AR and HCs, wherea…

MaleAllergyRhinitis Allergic PerennialAdolescentImmunologyBronchitiNitric OxideDermatitis AtopicAtopymedicineImmunology and AllergyHumansExhaled breath condensateExpirationBronchitisChildInflammation MediatorAsthmabusiness.industryMouth MucosaRhinitis Allergic SeasonalAtopic dermatitisDermatitis Atopic; Mouth Mucosa; Exhalation; Humans; Hydrogen-Ion Concentration; Asthma; Child; Nitric Oxide; Rhinitis Allergic Perennial; Rhinitis Allergic Seasonal; Interleukin-5; Nasal Mucosa; Inflammation Mediators; Bronchitis; Adolescent; Female; MaleHydrogen-Ion Concentrationmedicine.diseaseAsthmarespiratory tract diseasesNasal Mucosamedicine.anatomical_structureExhalationImmunologyExhaled nitric oxideFemaleInflammation MediatorsInterleukin-5businessRespiratory tractHuman
researchProduct

In activated mast cells, IL-1 up-regulates the production of several Th2-related cytokines including IL-9.

2000

Abstract Mast cells can play detrimental roles in the pathophysiology and mortality observed in anaphylaxis and other Th2-dominated allergic diseases. In contrast, these cells contribute to protective host defense mechanisms against parasitic worm infections. After IgE/Ag activation, mast cells can produce multiple cytokines that may enhance allergic inflammations, while a similar panel of Th2-related cytokines may support immunological strategies against parasites. Here we report that in primary mouse bone marrow-derived mast cells activated by ionomycin or IgE/Ag, the proinflammatory mediator IL-1 (α or β) up-regulated production of IL-3, IL-5, IL-6, and IL-9 as well as TNF, i.e., cytokin…

MaleAllergymedicine.medical_treatmentImmunologyDose-Response Relationship ImmunologicInflammationBone Marrow CellsBiologyImmunoglobulin EProinflammatory cytokineImmunophenotypingchemistry.chemical_compoundMiceTh2 CellsAdjuvants ImmunologicmedicineImmunology and AllergyAnimalsMast CellsRNA MessengerMice Inbred BALB CIonomycinInterleukin-9Cell DifferentiationSerum Albumin BovineImmunoglobulin Emedicine.diseaseUp-RegulationInterleukin 33Autocrine CommunicationKineticsCytokinechemistryIonomycinImmunologybiology.proteinCytokinesTumor necrosis factor alphaFemaleInterleukin-4medicine.symptomDinitrophenolsInterleukin-1Journal of immunology (Baltimore, Md. : 1950)
researchProduct

Short-Term Long Chain Omega3 Diet Protects from Neuroinflammatory Processes and Memory Impairment in Aged Mice

2011

Regular consumption of food enriched in omega3 polyunsaturated fatty acids (oméga3 PUFAs) has been shown to reduce risk of cognitive decline in elderly, and possibly development of Alzheimer's disease. Docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) are the most likely active components of oméga3-rich PUFAs diets in the brain. We therefore hypothesized that exposing mice to a DHA and EPA enriched diet may reduce neuroinflammation and protect against memory impairment in aged mice. For this purpose, mice were exposed to a control diet throughout life and were further submitted to a diet enriched in EPA and DHA during 2 additional months. Cytokine expression together with a thoroug…

MaleAnatomy and PhysiologyMouse[ SDV.AEN ] Life Sciences [q-bio]/Food and NutritionNeuroimmunologyNutritional Disorderslcsh:MedicineHippocampusHippocampusBiochemistryMiceLearning and Memory0302 clinical medicineImmune PhysiologyCognitive declinelcsh:Science2. Zero hungerchemistry.chemical_classification0303 health sciencesMultidisciplinaryFatty AcidsBrainfood and beveragesAnimal ModelsLipidsEicosapentaenoic acidmedicine.anatomical_structureEicosapentaenoic AcidNeurologyBiochemistryDocosahexaenoic acidAlimentation et NutritionCytokinesMedicineNeurogliaFemalelipids (amino acids peptides and proteins)Neurogenic InflammationResearch ArticlePolyunsaturated fatty acidmedicine.medical_specialtyDocosahexaenoic AcidsCognitive NeuroscienceImmunologyBiology03 medical and health sciencesModel OrganismsInternal medicineFatty Acids Omega-3medicineFood and NutritionAnimalsMemory impairmentWorking MemoryBiologyNeuroinflammationNutrition030304 developmental biologyInflammationMemory Disorderslcsh:RImmunityImmunologic SubspecialtiesDietMice Inbred C57BLNeuroanatomyEndocrinologychemistryDietary SupplementsClinical Immunologylcsh:Q[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition030217 neurology & neurosurgeryNeurosciencePLoS ONE
researchProduct

Delayed inhibition of angiotensin II receptor type 1 reduces secondary brain damage and improves functional recovery after experimental brain trauma*

2011

OBJECTIVE:: To investigate the regulation of the cerebral renin-angiotensin system and the effect of angiotensin II receptor type 1 inhibition on secondary brain damage, cerebral inflammation, and neurologic outcome after head trauma. DESIGN:: The expression of renin-angiotensin system components was determined at 15 mins, 3 hrs, 6 hrs, 12 hrs, and 24 hrs after controlled cortical impact in mice. Angiotensin II receptor type 1 was inhibited using candesartan (0.1, 0.5, 1 mg/kg) after trauma to determine its effect on secondary brain damage, brain edema formation, and inflammation. The window of opportunity was tested by delaying angiotensin II receptor type 1 inhibition for 30 mins, 1 hr, 2…

MaleAngiotensin receptorTraumatic brain injuryPoison controlInflammationBrain damagePharmacologyCritical Care and Intensive Care MedicineRenin-Angiotensin SystemMicemedicineAnimalsAngiotensin II receptor type 1biologybusiness.industryRecovery of Functionmedicine.diseaseMice Inbred C57BLNitric oxide synthaseCandesartanBrain InjuriesAnesthesiabiology.proteinmedicine.symptombusinessAngiotensin II Type 1 Receptor Blockersmedicine.drugCritical Care Medicine
researchProduct